INH preventive therapy (IPT) in HIV-infected south African children
Date
2011
Authors
Cotton , M. F.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
HIV-infected children have a high risk of acquiring tuberculosis. The World Health Organization (WHO) has released isoniazid preventive therapy (IPT) recommendations for adults and children living with HIV, based on efficacy studies, mainly in adults. Data from children appear conflicting. IPT guidelines for children were developed in response to WHO guidelines at a local meeting, followed by discussions. IPT should be given to all HIV-infected children after exposure to a source case if treatment for active disease is not required. For children whose mothers' HIV status was known antentally, when tuberculosis has been actively excluded in mothers and at infant follow-up, and when infants have commenced antiretroviral therapy in the first 3 months of life, IPT is not required. Otherwise, all infants and children should be given IPT for 6 months once active tuberculosis has been excluded.
Description
Keywords
anti human immunodeficiency virus agent, isoniazid, pyridoxine, antiviral therapy, chemoprophylaxis, childhood disease, health care access, health care delivery, high risk patient, human, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection, infection prevention, infection risk, isoniazid preventive therapy, patient assessment, post exposure prophylaxis, practice guideline, review, risk reduction, South Africa, tuberculosis, tuberculosis control, vitamin supplementation
Citation
Southern African Journal of HIV Medicine
40
http://www.scopus.com/inward/record.url?eid=2-s2.0-79959948833&partnerID=40&md5=6de1130f8996fb8489c80356c657fbec
40
http://www.scopus.com/inward/record.url?eid=2-s2.0-79959948833&partnerID=40&md5=6de1130f8996fb8489c80356c657fbec